Using brain activity to control robotic limbs

The newest technology from the University of Minnesota helped paralyzed patients or those with neurodegenerative diseases are able to control a robotic arm with their brains.

Using an electroencephalography (EEG) based brain-computer interface, researchers were able to record brain activity and convert the “thoughts” into actions with advanced signal processes and machine learning.

"This is the first time in the world that people can operate a robotic arm to reach and grasp objects in a complex 3D environment using only their thoughts without a brain implant," said Bin He, a University of Minnesota biomedical engineering professor and lead researcher on the study. "Just by imagining moving their arms, they were able to move the robotic arm."

Researchers tested the cap on eight healthy participants who gradually learned how to control the robotic arm. Participants began with imaging their own arms controlling the robotic arm in a 3D environment. They then controlled a virtual cursor on a computer screen before moving on the controlling the robotic arm to reach and grasp objects on a table. The final step was to move the robotic arm, grab objects scattered around a table and move them onto a shelf.

All participants were able to control the arm to pick up objects with an average success rate of 80 percent. Participants had an average success rate of 70 percent when trying to then place the object onto the shelf. The next step for researchers is to develop a brain-controlled robotic limb with the same success as the arm as well as expanding the technology to work with someone who had suffered a stroke or is paralyzed.

"This is exciting as all subjects accomplished the tasks using a completely noninvasive technique. We see a big potential for this research to help people who are paralyzed or have neurodegenerative diseases to become more independent without a need for surgical implants," said He.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup